Bain Capital on its acquisition of DSM Sinochem Pharmaceuticals, a global leader in sustainable antibiotics, next-generation statins and anti-fungals.
Creat Group Corporation on its acquisition of Biotest AG; securing unconditional UK clearance.
Crestview Partners in connection with the acquisition by its subsidiary, Accuride Corporation, of mefro wheels; conditional EU Phase I clearance.
Material Handling Systems, Inc., a portfolio company of Thomas H. Lee Partners, on its acquisition of VanRiet Material Handling Systems from Avedon Capital Partners and management.
Bain Capital and Cinven on their EUR 5.3 billion joint public takeover offer for the German pharmaceutical company Stada Arzneimittel AG; to date the largest private equity transaction ever realized in the German market.
CapVest Partners on its acquisition of Karro Food Group, a leading UK-based pork processing firm, from Endless LLP.
Bain Capital Private Equity on its acquisition of leading Italian tyre wholesaler Fintyre. Bain acquired the stake through its Europe IV Fund from London private equity firm BlueGem Capital Partners.
Bain Capital Private Equity on the acquisition of MSX International (MSXI).
Vista Equity Partners in its $1.6 billion take-private acquisition of Infoblox Inc.
Bain Capital Private Equity and Vista Equity Partners on the $2.7 billion acquisition of Vertafore.
Vista Equity Partners on the $1.65 billion acquisition of Cvent, Inc.
Montagu Private Equity on its sale of CliniSys to Roper Technologies.
GTCR on its pending £462 million sale of Premium Credit Limited to Cinven Partners LLP.
Ontario Teachers’ Pension Plan on the £365 million acquisition of Bridon Limited.
Bain Capital and Advent International on the DKK17 billion acquisition of Nordic card-payment company Nets Holding AS.
Ontario Teachers' Pension Plan on the acquisition of Burton's Biscuits Company.
Bain Capital on the successful merger control approval of the joint acquisition with Altor of EWOS before the EC and Norwegian authority.
Vista Equity Partners on the acquisition of Misys.
Representing Lafarge before the European and UK competition authorities on the creation of a joint venture comprising Lafarge and Anglo American (Tarmac)’s UK construction materials businesses.
Representing United Airlines on the European Commission’s investigation of its merger with Continental.
Schering-Plough before the European Commission on its US$41 billion merger with Merck.
Advising the Greek government on the State aid aspects of the restructuring and privatisation of Olympic Airlines and Olympic Airways Services.
Anheuser-Busch on the UK merger control review of its acquisition by InBev. The transaction was unconditionally cleared in phase one proceedings.
Schering-Plough/Organon BioSciences — Acting on a complex phase one pharmaceutical merger before the European Commission. The case was successfully approved with commitments in phase one proceedings.
Tomkins Plc v. European Commission — Representing a shareholder corporation before the European Commission, and in connection with annulment proceedings before the European General Court and Court of Justice.
European Commission Acrylics Cartel Investigation — Acting for a large international chemicals company during the European Commission's acrylics investigation.
Bio-Rad Laboratories Inc./Carl Zeiss Jena GmbH, Competition Commission (Phase II) Inquiry — Advising Bio-Rad Laboratories on the UK Competition Commission's investigation of Zeiss's acquisition of Bio-Rad's microscopy business.
